FDA Adverse Event Malfunction Summary report: N

ROCHE OMNI S

MDR report key: 7326478 · Received March 9, 2018

Report

Report Number
1823260-2018-00734
Event Type
Malfunction
Date Received
March 9, 2018
Date of Event
January 31, 2018
Report Date
May 1, 2018
Manufacturer
ROCHE DIAGNOSTICS
Product Code
CHL
PMA / PMN Number
K032311
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CO
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 0

THE CUSTOMER WAS USING A "CLOT CATCHER". THE "FACTORY HEPARINIZED SYRINGE" WAS A BS2 BLOOD SAMPLER.

Additional Manufacturer Narrative · 1

(B)(4). THIS EVENT OCCURRED IN (B)(6).

Additional Manufacturer Narrative · 1

THE INVESTIGATION WAS UNABLE TO FIND A DEFINITIVE ROOT CAUSE.

Description of Event or Problem · 1

THE CUSTOMER RECEIVED A QUESTIONABLE TOTAL HEMOGLOBIN (THB) RESULT FOR ONE PATIENT WITH A COBAS B221 ANALYZER WHEN COMPARED TO A XN 1000 HEMATOLOGY INSTRUMENT. OF THE DATA PROVIDED, THERE WERE ERRONEOUS RESULTS FOR THE THB AND HEMATOCRIT (HCT) TESTS. THE THB RESULT FROM THE COBAS B 221 WAS 5.45 G/DL. THE THB RESULT USING THE SAME SAMPLE IN ANOTHER LABORATORY WITH AN XN 1000 INSTRUMENT WAS 9.60 MG/DL. THE HCT RESULT FROM THE B 221 WAS 15.0%. THE HCT RESULT USING THE SAME SAMPLE IN ANOTHER LABORATORY WITH AN XN 1000 INSTRUMENT WAS 29.50%. THE CUSTOMER STATED THEY OBSERVED THIS SAME ISSUE WITH A DIFFERENT SAMPLE ON (B)(6) 2018. NO ERRONEOUS RESULTS WERE REPORTED OUTSIDE OF THE LABORATORY. THERE WAS NO ALLEGATION OF AN ADVERSE EVENT. THE QC RESULTS WERE CHECKED AND DETERMINED TO BE ACCEPTABLE. THE CUSTOMER STATED THAT THEY USED "FACTORY HEPARINIZED SYRINGES". THE LOT NUMBER AND EXPIRATION DATE OF THE THB CUVETTE WAS REQUESTED BUT WAS NOT PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
171642 ROCHE OMNI S BLOOD GAS ANALYZER CHL ROCHE DIAGNOSTICS NA NA

Patients

Seq Age Sex Outcome Treatment
1 18 YR